Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AAV Jude: An Interview with R. Jude Samulski.

Kevin Davies1

  • 1Executive Editor, Human Gene Therapy.

Human Gene Therapy
|January 20, 2021
PubMed
Summary

Richard Jude Samulski pioneered adeno-associated virus (AAV) research, establishing it as a key gene therapy vector. His foundational work paved the way for advanced AAV-based treatments and the multi-billion dollar company AskBio.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gene and genome duplications have contrasting impacts on biosynthetic and flower developmental pathways in California poppy.

The Plant cell·2026
Same author

Pan-phylum genomes of hornworts reveal conserved autosomes but dynamic accessory and sex chromosomes.

Nature plants·2025
Same author

Five Years of Progress in CRISPR Clinical Trials (2019-2024).

The CRISPR journal·2024
Same author

Letter to the editor commenting on the editorial: "The cost of everything and the value of nothing: New Zealand's under-investment in health".

The New Zealand medical journal·2024
Same author

A Story of Perseverance: An Interview with Matthew Porteus.

The CRISPR journal·2024
Same author

Comparative transcriptomics elucidates the cellular responses of an aeroterrestrial zygnematophyte to UV radiation.

Journal of experimental botany·2024

Area of Science:

  • Gene Therapy
  • Viral Vectors
  • Molecular Biology

Background:

  • Pioneering research in the early 1980s focused on adeno-associated virus (AAV) as a potential gene therapy vector.
  • Richard Jude Samulski's graduate studies established the foundation for AAV's role in the gene therapy field.
  • The field faced challenges, but Samulski's commitment to AAV's potential persisted.

Discussion:

  • Samulski's early AAV research profoundly influenced the trajectory of gene therapy development.
  • His continued belief in AAV's clinical applications guided his career and scientific contributions.
  • The acquisition of AskBio by Bayer for $4 billion underscores the significant commercial and therapeutic value of AAV technology.

Key Insights:

  • Adeno-associated virus (AAV) has emerged as a critical viral vector for gene therapy.
  • Early foundational research on AAV vectors has direct implications for modern therapeutic strategies.
  • Scientific perseverance is crucial for advancing novel biotechnologies like gene therapy.

Outlook:

  • Future gene therapy applications are expected to leverage AAV vectors for treating genetic disorders.
  • Continued innovation in AAV vector technology promises to expand therapeutic possibilities.
  • The commercial success of AAV-based ventures highlights a promising future for the gene therapy market.

Related Experiment Videos